Haemonetics Corp. buy Barrington Research
Start price
04.12.24
/
50%
€78.50
Target price
04.12.25
€102.93
Performance (%)
-18.47%
Price
31.07.25
€64.00
Summary
This prediction is currently active. The prediction for Haemonetics Corp. disappoints with a performance of -18.47%. This prediction currently runs until 04.12.25. The prediction end date can be changed by Barrington_Research at any time. Barrington_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 0.787% | 0.787% |
| iShares Core DAX® | -3.352% | -0.947% |
| iShares Nasdaq 100 | -0.740% | 3.167% |
| iShares Nikkei 225® | -1.885% | -0.531% |
| iShares S&P 500 | -0.952% | 2.583% |
Comments by Barrington_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Barrington_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.00
07.02.25
07.02.25
€91.64
07.02.26
07.02.26
12.28%
31.07.25
31.07.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€80.50
08.11.24
08.11.24
€100.71
08.11.25
08.11.25
-20.50%
31.07.25
31.07.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€68.00
23.09.24
23.09.24
€97.01
23.09.25
23.09.25
-6.62%
31.07.25
31.07.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€88.50
10.05.24
10.05.24
€99.33
10.05.25
10.05.25
-29.38%
11.05.25
11.05.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€78.50
12.04.24
12.04.24
€98.71
12.04.25
12.04.25
-34.39%
13.04.25
13.04.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€66.00
13.02.24
13.02.24
€97.90
13.02.25
13.02.25
-11.36%
14.02.25
14.02.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€81.50
03.11.23
03.11.23
€97.80
03.11.24
03.11.24
-18.40%
04.11.24
04.11.24